🕵️ Sunshine Biopharma Inc. ($SBFM)
SEC insider & ownership activity, last 12 months · CIK 1402328 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Mitchell P. Kopin | 10.0% | 13G | Aug 13, 2026 | filing ↗ | |
| Daniel B. Asher | 10.0% | 13G | Aug 13, 2026 | filing ↗ | |
| Intracoastal Capital LLC | 10.0% | 13G | Aug 13, 2026 | filing ↗ | |
| Bigger Michael | 9.5% | 13G | May 21, 2026 | filing ↗ | |
| ALTA Partners LLC | 8.6% | 13G | Jul 8, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Sep 15, 2026 | filing ↗ |
| Other events (8.01) | Sep 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Aug 25, 2026 | filing ↗ |
| Other events (8.01) | Aug 3, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 20, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 8, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 28, 2026 | filing ↗ |
| Material agreement (1.01) | May 18, 2026 | filing ↗ |
| Other events (8.01) | May 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 18, 2026 | filing ↗ |
| Earnings (2.02) | Apr 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 6, 2026 | filing ↗ |
| Other events (8.01) | Mar 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 6, 2026 | filing ↗ |
| Shareholder vote (5.07) | Feb 18, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 5, 2026 | filing ↗ |
| Shareholder vote (5.07) | Dec 11, 2025 | filing ↗ |
| Auditor change (4.01) | Sep 24, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 24, 2025 | filing ↗ |